AZR

3.6300.95%

Adial Pharmaceuticals Plans to Name Celia Economides CFO

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • Adial Pharmaceuticals expects to appoint Executive Vice President of Finance Celia Economides as chief financial officer, succeeding Vinay Shah. * The appointment is expected promptly following the reconvened 2026 annual stockholder meeting, subject to approval of certain proposals. * Chief Development Officer Matt Davidson is expected to become president and chief executive officer at the same time. * Economides joined in August 2026, having previously served as chief financial officer and chief business officer at CellCentric. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adial Pharmaceuticals Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610260800PRIMZONEFULLFEED9852921) on October 26, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings